Stock ScreenerStock IdeasPositive Investor SentimentPositive Investor SentimentInvestor sentiment can often be a leading indicator of stock performance. Sentiment Rating incorporates analyst revisions, insider activity, and short interest.
Stock ScreenerStock IdeasPositive Investor Sentiment
Zen Rating: A + 1 more
Sentiment Rating: A + 1 more
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NEPH | NEPHROS INC | $51.86M | $4.88 | $6.00 | 22.95% | N/A | Strong Buy | N/A | 1 | 0 | 5.99% | -11.72% | 22.75% | 17.18% |
| INDV | INDIVIOR PLC | $4.20B | $33.60 | $32.50 | -3.27% | 11.61% | Strong Buy | Strong Buy | 4 | 2 | -0.48% | 11.12% | N/A | N/A |
| ALLT | ALLOT LTD | $397.45M | $9.58 | $12.75 | 33.09% | 33.09% | Strong Buy | Strong Buy | 2 | 2 | 9.82% | 111.56% | 23.57% | 15.03% |
| AUPH | AURINIA PHARMACEUTICALS INC | $2.13B | $16.12 | $17.67 | 9.60% | 5.46% | Buy | Buy | 3 | 1 | 11.00% | 17.33% | 46.60% | 32.31% |
| TACT | TRANSACT TECHNOLOGIES INC | $44.90M | $4.44 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 5.03% | N/A | -2.27% | -1.61% |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.